ABIN2479420
antibody from antibodies-online
Targeting: ABCB1
ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2479420 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-ATP-Binding Cassette, Sub-Family B (MDR/TAP), Member 1 (ABCB1) antibody
- Antibody type
- Monoclonal
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- JSB-1
- Vial size
- 1 mL
Submitted references Charles F. Kettering Prize. P-glycoprotein and resistance to anticancer drugs.
Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistance.
Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemia.
Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance.
Ling V
Cancer 1992 May 15;69(10):2603-9
Cancer 1992 May 15;69(10):2603-9
Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistance.
Scheper RJ, Bulte JW, Brakkee JG, Quak JJ, van der Schoot E, Balm AJ, Meijer CJ, Broxterman HJ, Kuiper CM, Lankelma J
International journal of cancer 1988 Sep 15;42(3):389-94
International journal of cancer 1988 Sep 15;42(3):389-94
Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemia.
Ma DD, Scurr RD, Davey RA, Mackertich SM, Harman DH, Dowden G, Isbister JP, Bell DR
Lancet (London, England) 1987 Jan 17;1(8525):135-7
Lancet (London, England) 1987 Jan 17;1(8525):135-7
Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance.
Bell DR, Gerlach JH, Kartner N, Buick RN, Ling V
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985 Mar;3(3):311-5
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985 Mar;3(3):311-5
No comments: Submit comment
No validations: Submit validation data